Issue 007. Digital health formulary wars heat up. $40M price tag for a digital drug.

Get E&O weekly. | Subscribe | Digital health research from Brian Dolan.

Welcome to E&O.

Last week's newsletter had a likely-not-to-be-repeated 89 percent open rate. Here's what's happening this week:

• Your editor is preparing to take his 3-year-old and 5-year-old camping for the first time this weekend. Hit reply to talk me out of it (or to send more marshmallows).
• Dexcom CEO Kevin Sayer told Jim Cramer in the next 12 months the company will launch the G6 version of its CGM that sends data direct-to-Apple Watch (bypassing the iPhone).
• Benjamin D'hont of Alcimed has a helpful overview of the current state of digital therapeutics here.
• Elsewhere, I've heard some curmudgeons throwing cold water on digital health companies that call themselves "digital therapeutics" if they use either CBT or real live